Skip to main content

Table 4 Characteristics of individuals with or without postoperative RVH

From: Multiple factors in the prediction of risk of recurrent vitreous haemorrhage after sutureless vitrectomy for non-clearing vitreous haemorrhage in patients with diabetic retinopathy

 

23G(n = 70)

25G(n = 97)

No RVH(n = 52)

RVH(n = 18)

p-value

No RVH(n = 76)

RVH(n = 21)

p-value

Sex (male/female)

31 (59.6)

12 (66.7)

0.596

46 (60.5)

14 (66.7)

0.608

Age, years (mean ± SD)

56.94 ± 10.45

48.22 ± 11.46

0.006

53.96 ± 11.85

43.19 ± 12.52

< 0.001

Duration of diabetes, years

10.00 (5.00–17.00)

5.00 (3.00–9.25)

0.007

12.50 (8.50–17.00)

6.00 (2.00–15.00)

0.003

Preoperative fasting blood glucose level, mmol/L

5.88 (4.88–7.44)

5.27 (3.99–6.97)

0.149

5.93 (5.09–7.06)

6.04 (4.21–7.97)

0.646

Preoperative systolic blood pressure,mmHg

137.60 (100–183)

139.22 (92–187)

0.702

135.03 (88–190)

140.14 (100–187)

0.464

Serum creatinine, μmol/L

70.40 (53.33–88.78)

108.80 (66.78–231.28)

0.002

71.80 (56.08–118.00)

95.00 (68.80–373.60)

0.009

Urea, mmol/L

6.47 (5.17–7.58)

8.14 (5.42–13.36)

0.066

5.88 (4.79–7.81)

9.40 (5.49–14.04)

0.005

Triamcinolone acetonide usage, n(%)

48 (92.3)

15 (83.3)

0.523

45 (59.2)

14 (66.7)

0.536

Electral-coagulation usage (fibrovascular membrane), n(%)

10 (19.2)

2 (11.1)

0.671

6 (7.9)

1 (4.8)

0.988

Air-fluid exchange, n(%)

49 (94.2)

17 (94.4)

1

52 (68.4)

14 (66.7)

0.879

Pre-pan-retinal photocoagulation, n(%)

9 (17.3)

3 (16.7)

1

14 (18.4)

1 (4.8)

0.233

Anti-vascular endothelial growth drug usage, n(%)

9 (17.3)

1 (5.6)

0.402

25 (32.9)

8 (38.1)

0.656